A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sunvozertinib | CAS 2370013-12-8 - Request Quote

Picture of Sunvozertinib

Sunvozertinib

SZ CAT No:SZ-S131001
CAS No
2370013-12-8
Mol.F.
C29H35ClFN7O3
Mol.Wt.
584.1
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Sunvozertinib is chemically (R)-N-(5-((4-((5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)phenyl)amino)pyrimidin-2-yl)amino)-2-(3-(dimethylamino)pyrrolidin-1-yl)-4-methoxyphenyl)acrylamide. Sunvozertinib is supplied with detailed characterization data compliant with regulatory guideline. Sunvozertinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Sunvozertinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2370013-12-8

Purchase 2370013-12-8

Order 2370013-12-8

Enquire 2370013-12-8

price of 2370013-12-8

2370013-12-8 Supplier

2370013-12-8 Manufacturer

2370013-12-8 Exporter

buy high quality Sunvozertinib

Purchase Sunvozertinib

Sunvozertinib suppliers

Sunvozertinib manufacturers

Sunvozertinib price

Order Sunvozertinib

Enquire Sunvozertinib

Sunvozertinib cost

Sunvozertinib Supplier

Sunvozertinib Distributor

Sunvozertinib for Method Validation

Sunvozertinib Reference Standard

Sunvozertinib for ANDA Filing

Sunvozertinib for Forced Degradation Studies

Sunvozertinib Identification Standards

Sunvozertinib for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.